[go: up one dir, main page]

NO20044005L - HFA-Suspensjonsformulering inneholdende et anticholinergicum - Google Patents

HFA-Suspensjonsformulering inneholdende et anticholinergicum

Info

Publication number
NO20044005L
NO20044005L NO20044005A NO20044005A NO20044005L NO 20044005 L NO20044005 L NO 20044005L NO 20044005 A NO20044005 A NO 20044005A NO 20044005 A NO20044005 A NO 20044005A NO 20044005 L NO20044005 L NO 20044005L
Authority
NO
Norway
Prior art keywords
anticholinergic
hfa
formulation containing
suspension formulation
hfa suspension
Prior art date
Application number
NO20044005A
Other languages
English (en)
Norwegian (no)
Inventor
Christel Schmelzer
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=28050989&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20044005(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of NO20044005L publication Critical patent/NO20044005L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/12Aerosols; Foams
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20044005A 2002-03-28 2004-09-23 HFA-Suspensjonsformulering inneholdende et anticholinergicum NO20044005L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10214263A DE10214263A1 (de) 2002-03-28 2002-03-28 HFA-Suspensionsformulierungen enthaltend ein Anticholinergikum
PCT/EP2003/002898 WO2003082252A1 (fr) 2002-03-28 2003-03-20 Formulations de suspensions contenant un gaz propulseur hfa et un anticholinergique

Publications (1)

Publication Number Publication Date
NO20044005L true NO20044005L (no) 2004-10-05

Family

ID=28050989

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20044005A NO20044005L (no) 2002-03-28 2004-09-23 HFA-Suspensjonsformulering inneholdende et anticholinergicum

Country Status (26)

Country Link
EP (2) EP1492513B1 (fr)
JP (1) JP4480401B2 (fr)
KR (1) KR101066801B1 (fr)
CN (1) CN1329023C (fr)
AT (1) ATE339953T1 (fr)
AU (1) AU2003209743B2 (fr)
BR (1) BR0308764A (fr)
CA (1) CA2479640C (fr)
CY (1) CY1105543T1 (fr)
DE (2) DE10214263A1 (fr)
DK (1) DK1492513T3 (fr)
EA (1) EA007239B1 (fr)
EC (1) ECSP045321A (fr)
ES (1) ES2273020T3 (fr)
HR (1) HRP20040889B1 (fr)
IL (2) IL163697A0 (fr)
ME (1) ME00247B (fr)
MX (1) MXPA04009337A (fr)
NO (1) NO20044005L (fr)
NZ (1) NZ536043A (fr)
PL (1) PL371296A1 (fr)
PT (1) PT1492513E (fr)
RS (1) RS52178B (fr)
UA (1) UA78557C2 (fr)
WO (1) WO2003082252A1 (fr)
ZA (1) ZA200405638B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1809243B2 (fr) 2004-07-02 2022-06-08 Boehringer Ingelheim International GmbH Formulations de suspensions aerosol contenant tg 227 ea en tant qu'agent propulseur
TWI396541B (zh) * 2005-10-10 2013-05-21 Boehringer Ingelheim Int 用於治療呼吸疾病之新穎藥物組合
GB201200504D0 (en) * 2011-12-19 2012-02-22 Teva Branded Pharmaceutical Prod R & D Inc An inhaler
GB201200525D0 (en) 2011-12-19 2012-02-29 Teva Branded Pharmaceutical Prod R & D Inc An inhalable medicament
EP2705838A1 (fr) * 2012-09-06 2014-03-12 Xspray Microparticles Ab Préparations de tiotropium
JP2016503390A (ja) * 2012-10-23 2016-02-04 シプラ・リミテッド 医薬組成物
US10034866B2 (en) 2014-06-19 2018-07-31 Teva Branded Pharmaceutical Products R&D, Inc. Inhalable medicament comprising tiotropium
CN107056629B (zh) * 2017-04-27 2019-04-30 河北科技大学 一种无水卤化胆碱及其衍生物单晶的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5610163A (en) * 1989-09-16 1997-03-11 Boehringer Ingelheim Gmbh Esters of thienyl carboxylic acids and amino alcohols and their quaternization products
GB2326334A (en) * 1997-06-13 1998-12-23 Chiesi Farma Spa Pharmaceutical aerosol compositions
EP1102579B1 (fr) * 1998-08-04 2003-03-19 Jago Research Ag Formulations d'aerosol a usage medical
DZ2947A1 (fr) * 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
DE19921693A1 (de) * 1999-05-12 2000-11-16 Boehringer Ingelheim Pharma Neuartige Arzneimittelkompositionen auf der Basis von anticholinergisch wirksamen Verbindungen und ß-Mimetika
IT1317846B1 (it) * 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
GB0009605D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Medicaments
ES2228965T3 (es) * 2000-10-12 2005-04-16 BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG Monohidrato cristalino de bromuro de tiotropio, procedimiento para su preparacion y su uso para la produccion de un medicamento.
AU2002210575A1 (en) * 2000-10-31 2002-05-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg Novel medicament compositions based on anticholinergics and corticosteroids
DE10056104A1 (de) * 2000-11-13 2002-05-23 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Tiotropiumsalzen und Salzen des Salmeterols

Also Published As

Publication number Publication date
CN1329023C (zh) 2007-08-01
CY1105543T1 (el) 2010-07-28
EP1695701B1 (fr) 2015-01-07
EA200401190A1 (ru) 2005-04-28
PT1492513E (pt) 2006-12-29
DE10214263A1 (de) 2003-10-16
CN1642534A (zh) 2005-07-20
HK1079091A1 (en) 2006-03-31
UA78557C2 (en) 2007-04-10
EA007239B1 (ru) 2006-08-25
ME00247B (fr) 2011-05-10
ZA200405638B (en) 2005-07-27
IL163697A0 (en) 2005-12-18
AU2003209743B2 (en) 2008-03-06
ECSP045321A (es) 2005-01-28
EP1492513B1 (fr) 2006-09-20
WO2003082252A1 (fr) 2003-10-09
IL163697A (en) 2011-03-31
HRP20040889B1 (hr) 2012-11-30
ES2273020T3 (es) 2007-05-01
DK1492513T3 (da) 2006-12-18
KR20040098031A (ko) 2004-11-18
MEP47408A (en) 2011-02-10
EP1695701A3 (fr) 2010-04-28
CA2479640A1 (fr) 2003-10-09
ATE339953T1 (de) 2006-10-15
NZ536043A (en) 2005-09-30
AU2003209743A1 (en) 2003-10-13
DE50305118D1 (de) 2006-11-02
MXPA04009337A (es) 2005-01-25
EP1492513A1 (fr) 2005-01-05
YU85904A (sh) 2006-08-17
BR0308764A (pt) 2005-01-11
JP4480401B2 (ja) 2010-06-16
EP1695701A2 (fr) 2006-08-30
KR101066801B1 (ko) 2011-09-22
CA2479640C (fr) 2010-09-28
PL371296A1 (en) 2005-06-13
RS52178B (sr) 2012-10-31
HRP20040889A2 (en) 2004-12-31
JP2005529087A (ja) 2005-09-29

Similar Documents

Publication Publication Date Title
CA2107232A1 (fr) Compositions azeotropes ou presentant les proprietes d'un azeotrope a base de 1,1,2,2-tetrafluoroethane
JP2008036429A5 (fr)
ES2156412T3 (es) Mezclas con 1,1,1,3,3-pentafluorobutano.
ATE164864T1 (de) Flüssiges kohlendioxid enthaltende treibmittel
WO2005048976A3 (fr) Mousse therapeutique
CO4410246A1 (es) Proceso para preparar una espuma de poliuretano en presencia de un agente inflador de hidrocarburo
EP2036943A3 (fr) Compositions contenant des oléfines substituées par du fluor
DE69522441D1 (de) Zusammensetzungen aus fluorkohlenwasserstoffen
NO20044005L (no) HFA-Suspensjonsformulering inneholdende et anticholinergicum
AR248158A1 (es) Composicion casi-azeotropica para uso como refrigerante y procedimiento para producir refrigeracion mediante su empleo.
ES2178817T3 (es) Formulaciones medicinales de aerosol.
CY1111089T1 (el) Συνθεση ψυκτικου μεσου
BR9812508A (pt) Processo para preparar espumas de poliisocianurato modificadas com uretano ou poliuretano rìgidas, espuma de poliisocianurato modificada com uretano ou poliuretano rìgida, e, composição reativa a isocianato polifuncional
BRPI0713310A2 (pt) aumentadores de tamanho de cÉlula para espumas de poliestireno
MXPA05005692A (es) Refrigerantes para enfriador.
CA2329989A1 (fr) Mousses a faible emission fugitive, a forte productivite, et procedes de mousses
MX2007007550A (es) Composiciones de espuma de poliestireno expandido, retardadoras de la flama.
PT1345987E (pt) Processo para fabrico de espumas de poliuretano de pele integral
BR9808818A (pt) Composição constituìda essencialmente de 1, 1, 1, 3, 3-pentafluorobutano e de um hidrocarboneto, utilização de composições azeotrópicas ou pseudo-azeotrópicas, agente espumante para espumas celulares poliméricas e pré-mistura para espuma de poliuretano.
EP0626421A4 (fr) Composition d'agent porogene, production de mousse au moyen de ladite composition et mousse ainsi produite.
CA2305777A1 (fr) Procede d'expansion haute productivite avec emission reduite de cov fugitif
DK0552075T3 (da) Blandinger af 1,1,1-trifluorethan og perfluorpropan og deres anvendelse som kølemedier, drivmidler til aerosoler eller midler til ekspansion af plastskum
MY134068A (en) Azeotrope-like compositions of pentafluoropropane
NO20081232L (no) Agarosebelagt, agarosesekretorisk cellekule, samt fremstilling og anvendelse derav
NO953675L (no) Azeotrop-lignende blandinger av 1,1,1,2,3,3,3-heptafluor propan og 1,1-difluoretan, og anvendelse av slike

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application